biotechnology company
H.R.34, 21st Century Cures Act (P.L.114-255). S.2912, Trickett Wendler Right to Try Act of 2016. Issues related to Pharma supply chain and 340B Program. Medicare reimbursement issues. H.R.5122, To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models; issues related to Demonstration Programs. S.3040/H.R.5926, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; H.R.5054/S.2956, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; H.R.2028, Further Continuing and Security Assistance Appropriations Act, 2017 (P.L.114-254); vial size issues.
HCR - Health Issues MMM - Medicare/Medicaid BUD - Budget/Appropriations
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
CROSSROADS STRATEGIES, LLC
800 North Capitol Street, NW, Suite 800, Washington, DC, 20002, US
TODD MATTHEW WEISS MATHEW LAPINSKI JOHN GREEN STEWART HALL HUNTER MOORHEAD MATT WISE STEVE TILTON ANNE BRADY JAKE PERRY ELIZABETH ALYSON HART TODD MATTHEW WEISS MATHEW LAPINSKI JOHN GREEN STEWART HALL HUNTER MOORHEAD MATT WISE STEVE TILTON ANNE BRADY JAKE PERRY ELIZABETH ALYSON HART TODD MATTHEW WEISS MATHEW LAPINSKI JOHN GREEN STEWART HALL HUNTER MOORHEAD MATT WISE STEVE TILTON ANNE BRADY JAKE PERRY ELIZABETH ALYSON HART